David Hallal

2021

In 2021, David Hallal earned a total compensation of $16.8M as Chairman and Former Chief Executive Office at Allovir, a 10% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$81,562
Option Awards$9,781,229
Salary$219,000
Stock Awards$6,620,880
Other$95,042
Total$16,797,713

Hallal received $9.8M in option awards, accounting for 58% of the total pay in 2021.

Hallal also received $81.6K in non-equity incentive plan, $219K in salary, $6.6M in stock awards and $95K in other compensation.

Rankings

In 2021, David Hallal's compensation ranked 439th out of 12,415 executives tracked by ExecPay. In other words, Hallal earned more than 96.5% of executives.

ClassificationRankingPercentile
All
439
out of 12,415
97th
Division
Manufacturing
138
out of 5,501
98th
Major group
Chemicals And Allied Products
42
out of 2,371
98th
Industry group
Drugs
37
out of 2,092
98th
Industry
Biological Products, Except Diagnostic Substances
16
out of 449
96th
Source: SEC filing on April 6, 2022.

Hallal's colleagues

We found four more compensation records of executives who worked with David Hallal at Allovir in 2021.

2021

Diana Brainard

Allovir

Chief Executive Officer

2021

Vikas Sinha

Allovir

Chief Financial Officer

2021

Agustin Melian

Allovir

Chief Medical Officer

2021

Jeroen van Beek

Allovir

Chief Commercial Officer

News

In-depth

You may also like